Hsu-Shan Huang

14PUBLICATIONS
19CO-AUTHORS
Molecular targetsBiologically active moleculesCancer geneticsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 27, 2026
Phenotype-Oriented Characterization of NSC828786 Identifies Convergent HPN-AMACR-Associated Transcriptomic Signatures in Prostate Adenocarcinoma and Broad-Spectrum Antiproliferative Activity.

|Nov 25, 2023
Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent.

Harold A Chinyama, Li Wei, Ntlotlang Mokgautsi

|Jul 29, 2023
In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer.

Lung-Ching Chen, Ntlotlang Mokgautsi, Yu-Cheng Kuo

|Jun 28, 2023
Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis.

Harshita Nivrutti Khedkar, Lung-Ching Chen, Yu-Cheng Kuo

|Jan 21, 2023
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents.

Yi-Fong Chen, Bashir Lawal, Li-Jiau Huang

|Jan 21, 2023
Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.

Ntlotlang Mokgautsi, Yu-Cheng Kuo, Chien-Hsin Chen

Pageof 3

Frequent Collaborators

13 joint publications

Alexander T H Wu

10 joint publications

Ntlotlang Mokgautsi

8 joint publications

Bashir Lawal

3 joint publications

Harshita Nivrutti Khedkar